TABLE 2.
Summary of data by ABGM
| Parameter | No. of ABGMs from hospitals with bed size of:
|
|||
|---|---|---|---|---|
| 0-50 | 51-250 | >250 | Total (%) | |
| Summarized data presentationa | 9 | 68 | 122 | 199 (95.2) |
| Organisms separated by morphology | 10 | 63 | 114 | 187 (89.5) |
| Reported as % susceptible | 10 | 73 | 120 | 203 (97.1) |
| Duplicate isolate notation | 2 | 5 | 17 | 24 (11.5) |
| ABGM frequency | ||||
| More than annually (<12 mo) | 1 | 4 | 20 | 25 (16.8) |
| Annually | 6 | 44 | 70 | 120 (80.5) |
| Less than annually (>12 mo) | 2 | 1 | 1 | 4 (2.7) |
| Collection period description (i.e., mo and yr) | 5 | 52 | 94 | 151 (72.2) |
| No. of isolates reported | 11 | 73 | 119 | 203 (97.1) |
| Less than 10 isolatesb | 6 | 37 | 42 | 85 (40.7) |
| Name used in antimicrobial agent description | ||||
| All generic | 11 | 56 | 99 | 166 (79.4) |
| All generic and all brand | 0 | 3 | 6 | 9 (4.3) |
| All generic and some brand | 0 | 4 | 5 | 9 (4.3) |
| Some generic and some brand | 0 | 11 | 14 | 25 (12.0) |
| Antimicrobial abbreviations used | ||||
| NCCLS recommended | 1 | 14 | 7 | 22 (10.5) |
| Other | 1 | 6 | 30 | 37 (17.7) |
| Presentation of susceptibility data not reported | ||||
| Dash | 0 | 6 | 20 | 26 (12.4) |
| Blank | 6 | 48 | 75 | 129 (61.7) |
| Other method (e.g., shading, asterisk, etc.) | 5 | 20 | 29 | 54 (25.8) |
| Total no. of ABGMs | 11 | 74 | 124 | 209 |
a
Defined as data presented in tabular form.
b
Defined as the number of ABGMs with at least one organism reported with less than 10 isolates (n = 203).